• OPEN AN ACCOUNT
Indian Indices
Nifty
25,111.45 -100.60
(-0.40%)
Sensex
81,670.12 -589.12
( -0.72%)
Bank Nifty
56,828.80 -340.15
( -0.59%)
Nifty IT
37,138.55 -522.15
( -1.39%)
Global Indices
Nasdaq
44,515.72 239.93
(0.54%)
Dow Jones
6,318.70 34.00
(0.54%)
Hang Seng
39,856.94 193.54
(0.49%)
Nikkei 225
8,972.64 46.09
(0.52%)
Forex
USD-INR
85.91 0.01
(0.01%)
EUR-INR
99.83 -0.21
(-0.21%)
GBP-INR
115.15 -0.11
(-0.09%)
JPY-INR
0.58 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Larsen & Toubro Ltd
Industry :  Engineering - Turnkey Services
BSE Code
ISIN Demat
Book Value()
500510
INE018A01030
522.7424234
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LT
41.05
477841.13
EPS(TTM)
Face Value()
Div & Yield %
84.63
2
0.98
 

Concord Drugs reports consolidated net profit of Rs 0.04 crore in the March 2025 quarter
May 24,2025
Net profit of Concord Drugs reported to Rs 0.04 crore in the quarter ended March 2025 as against net loss of Rs 0.34 crore during the previous quarter ended March 2024. Sales declined 33.57% to Rs 10.39 crore in the quarter ended March 2025 as against Rs 15.64 crore during the previous quarter ended March 2024.

For the full year,net profit declined 27.66% to Rs 0.34 crore in the year ended March 2025 as against Rs 0.47 crore during the previous year ended March 2024. Sales rose 0.71% to Rs 45.24 crore in the year ended March 2025 as against Rs 44.92 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales10.3915.64 -34 45.2444.92 1
OPM %10.112.24 -9.179.02 -
PBDT0.44-0.15 LP 2.122.18 -3
PBT0.06-0.55 LP 0.690.63 10
NP0.04-0.34 LP 0.340.47 -28